Testing effectiveness (Phase 2)Study completedNCT03416244
What this trial is testing
Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
Who this might be right for
Esophageal CancerOesophageal CancerOesophageal Cancer Metastatic+5 more
AIO-Studien-gGmbH 66